ES2096934T3 - Composicion para la liberacion controlada de una sustancia activa y metodo para la preparacion de dicha composicion. - Google Patents

Composicion para la liberacion controlada de una sustancia activa y metodo para la preparacion de dicha composicion.

Info

Publication number
ES2096934T3
ES2096934T3 ES93916290T ES93916290T ES2096934T3 ES 2096934 T3 ES2096934 T3 ES 2096934T3 ES 93916290 T ES93916290 T ES 93916290T ES 93916290 T ES93916290 T ES 93916290T ES 2096934 T3 ES2096934 T3 ES 2096934T3
Authority
ES
Spain
Prior art keywords
composition
glucan
pct
active substance
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93916290T
Other languages
English (en)
Inventor
Arie Cornelis Besemer
Der Lugt Jan Pieter Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Original Assignee
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO filed Critical Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Application granted granted Critical
Publication of ES2096934T3 publication Critical patent/ES2096934T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

EN LA INVENCION SE PRESENTA UNA COMPOSICION PARA LA LIBERACION RETARDADA DE UNA SUSTANCIA ACTIVA, EN DONDE LA SUSTANCIA ACTIVA SE ENCUENTRA INCORPORADA EN UNA MATRIZ POLISACARIDA QUE CONSISTE EN UN GLUCANO DE CADENA RECTA ESENCIALMENTE CRISTALINO Y QUE CONTIENE UN AGENTE DEGRADADOR DEL GLUCANO. EL GLUCANO ES EN PARTICULAR UN (ALFA)GLUCANO QUE TIENE ESENCIALMENTE UNA ESTRUCTURA HELICOIDAL. EL AGENTE DEGRADADOR DEL GLUCANO ES PREFERENTEMENTE UNA (ALFA)-AMILASA. LA COMPOSICION PUEDE CONTENER MATERIALES DE ALTO PESO MOLECULAR TALES COMO PROTEINAS, ALERGENOS, SUSTANCIAS PARA VACUNAS Y MICROORGANISMOS, Y PREFERENTEMENTE SE PRESENTAN COMO COMPRIMIDOS.
ES93916290T 1992-07-03 1993-07-02 Composicion para la liberacion controlada de una sustancia activa y metodo para la preparacion de dicha composicion. Expired - Lifetime ES2096934T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9201196A NL9201196A (nl) 1992-07-03 1992-07-03 Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat.

Publications (1)

Publication Number Publication Date
ES2096934T3 true ES2096934T3 (es) 1997-03-16

Family

ID=19861015

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93916290T Expired - Lifetime ES2096934T3 (es) 1992-07-03 1993-07-02 Composicion para la liberacion controlada de una sustancia activa y metodo para la preparacion de dicha composicion.

Country Status (12)

Country Link
US (1) US5629018A (es)
EP (1) EP0648115B1 (es)
JP (1) JPH07508532A (es)
AT (1) ATE145821T1 (es)
AU (1) AU677591B2 (es)
CA (1) CA2139493A1 (es)
DE (1) DE69306390T2 (es)
DK (1) DK0648115T3 (es)
ES (1) ES2096934T3 (es)
GR (1) GR3022646T3 (es)
NL (1) NL9201196A (es)
WO (1) WO1994001091A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
DE19737481A1 (de) 1997-08-28 1999-03-04 Hoechst Ag Sphärische lineare Polysaccharide enthaltende Mikropartikel
AU1786799A (en) * 1997-12-18 1999-07-05 Instituut Voor Agrotechnologisch Onderzoek (Ato-Dlo) Composition for the controlled release of active compounds
DE19860373B4 (de) * 1998-12-28 2004-02-19 Celanese Ventures Gmbh Mundpflegemittel und Verwendung von sphärischen Mikropartikeln
JP3742335B2 (ja) * 2001-12-20 2006-02-01 富士通株式会社 入出力バッファ回路
US6929817B2 (en) * 2002-05-14 2005-08-16 National Starch & Chemical Investment Holding Corporation Slowly digestible starch product
US6890571B2 (en) * 2002-05-14 2005-05-10 National Starch And Chemical Investment Holding Corporation Slowly digestible starch product
US7081261B2 (en) * 2002-05-14 2006-07-25 National Starch And Chemical Investment Holding Corporation Resistant starch prepared by isoamylase debranching of low amylose starch
EP1645568A4 (en) 2003-07-11 2007-06-27 Asahi Kasei Chemicals Corp FUNCTIONAL AMYLACEE POWDER
US20050033157A1 (en) * 2003-07-25 2005-02-10 Klein Dean A. Multi-modality marking material and method
US20070071810A1 (en) * 2003-08-26 2007-03-29 Kenichi Kudo Additive for tablets
CN101155636B (zh) * 2005-02-07 2011-07-27 江崎格力高株式会社 含有α-1,4-葡聚糖的吸附剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493652A (en) * 1962-09-14 1970-02-03 Charles W Hartman Controlled release medicament
JPH0747539B2 (ja) * 1986-10-22 1995-05-24 東京田辺製薬株式会社 胆汁酸固形製剤
DE3721574A1 (de) * 1987-06-30 1989-01-12 Kettelhack Riker Pharma Gmbh Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
US4859377A (en) * 1987-07-10 1989-08-22 The United States Of America, As Represented By The Secretary Of Agriculture Starch encapsulation of entomopathogens

Also Published As

Publication number Publication date
EP0648115A1 (en) 1995-04-19
AU4589293A (en) 1994-01-31
JPH07508532A (ja) 1995-09-21
ATE145821T1 (de) 1996-12-15
NL9201196A (nl) 1994-02-01
EP0648115B1 (en) 1996-12-04
DE69306390D1 (de) 1997-01-16
AU677591B2 (en) 1997-05-01
CA2139493A1 (en) 1994-01-20
GR3022646T3 (en) 1997-05-31
US5629018A (en) 1997-05-13
DE69306390T2 (de) 1997-06-05
DK0648115T3 (da) 1997-06-02
WO1994001091A1 (en) 1994-01-20

Similar Documents

Publication Publication Date Title
ES2096934T3 (es) Composicion para la liberacion controlada de una sustancia activa y metodo para la preparacion de dicha composicion.
ES2029269T5 (es) Una formulacion de liberacion lenta.
WO1992002212A3 (en) Use of interfacially-polymerized membranes in delivery devices
DK0789559T3 (da) Farmaceutisk præparat indeholdende en smeltelig bærer og en fremgangsmåde til fremstilling deraf
CA2199993A1 (en) Methods of delivering materials into the skin, and compositions used therein
BR9607752A (pt) Formulação farmacêutica de microcápsula de liberação controlada, processo para sua preparação, e, processo de uso das microcápsulas
ATE240719T1 (de) Pharmazeutische tablette mit verzögerter freisetzung, enthaltend eine matrix aus quervernetzter amylose und hydroxypropyl methylzellulose
AU7782794A (en) Transdermal therapeutic system with acetylsalicylic acid as active substance
CA2263557A1 (en) Implant consisting of a carrier material containing medical substances and method to produce such an implant
GR3022195T3 (en) Composition for controlled release of an active substance and method for the preparation of such a composition.
HUP9802498A2 (hu) Eljárás és berendezés hatóanyagoknak valamely szűrőanyagra történő felhordására
AU8229998A (en) Modified glycosides, compositions comprised thereof and methods of use thereof
AU1191795A (en) Deuterated active substances in transdermal application
AU3844995A (en) Implantable device for administration of active substances to plants
ES2113803A1 (es) Metodo para el tratamiento de plantas.
ES2019024A6 (es) Procedimiento de preparar una composicion farmaceutica a base de trimebutina.
CA2027833A1 (en) Implant material, method for the manufacture thereof and procedure for the application of the material
陈受谦 et al. Experimental Observation on Osteogenetic Effects of Allogenic Decalcified Bone Matrix
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
ES8601689A1 (es) Procedimiento de preparar composiciones farmaceuticas solidas de liberacion sostenida
GR1004100B (el) Συστημα ελεγχομενης απελευθερωσης, αιθεριων ελαιων, αρωματων και διαφορων αλλων πτητικων βιολογικα ενεργων ουσιων
RU92016566A (ru) Биокерамическая система для ввода биологически активных соединений, способ ее получения, фармацевтическое средство, способ применения биокерамической системы

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 648115

Country of ref document: ES